José Almeida Bastos and Richard Pilnik integrate the Board of Directors of the biggest pharmaceutical company in Portugal
José Almeida Bastos is now part of BIAL’s Executive Committee and responsible for both national and international commercial operations.
Richard Pilnik has a 35 year career in the health sector, and is now non-executive member of BIAL’s Board of Directors.
According to António Portela, CEO of BIAL, “it is an honor to have José Almeida Bastos and Richard Pilnik onboard. With their wide experience, they will endow the company with a more prepared structure to deal with upcoming challenges within the strategic lines we have defined, the research and development of new medicines, consolidated in an international scale.
The Board of Directors of BIAL consists of 8 members: Luís Portela (Chairman), António Portela (CEO), Richard Pilnik (Non-Executive), Isabel Morgado, José Redondo, Miguel Portela, Patrício Soares da Silva and José Almeida Bastos.